LabConnect Welcomes Mitch Blumenfeld as New CFO to Drive Financial Strategy

LabConnect Announces Appointment of New CFO

LabConnect, a leading central laboratory solutions provider, is thrilled to announce the appointment of Mitch Blumenfeld as its new Chief Financial Officer (CFO), effective August 4, 2025. This strategic decision marks a significant milestone in the company’s commitment to strengthening its financial leadership and operational excellence.

Mitch Blumenfeld brings over 30 years of extensive experience as a financial executive across various high-growth sectors, including pharmaceutical services, wholesale pharmaceutical distribution, diversified manufacturing, and consumer products. His impressive background positions him uniquely to guide LabConnect through its next phase of growth. Prior to his new role, Blumenfeld served as CFO at Network Partners Group, a global consulting firm specializing in life sciences and medical devices, where he managed a diverse portfolio of financial operations and regulatory affairs.

A Proven Record of Success

Blumenfeld’s career trajectory illustrates a strong track record of leadership and innovation. He has held key financial leadership positions at several notable companies, including Signant Health—a global leader in software and services for clinical research—and PCI Pharma Services, a well-respected contract development and manufacturing organization. His tenures at AmerisourceBergen Corporation and various divisions of General Electric further enhance his credibility and expertise in managing complex financial landscapes.

Mitch holds an M.S. in Computer Science from Virginia Tech and a B.S. in Computer Science and Engineering from Bucknell University. His solid educational background complements his practical experience, ensuring he is well-equipped to handle the financial complexities of a rapidly evolving industry.

Commitment to Growth

Wes Wheeler, CEO of LabConnect, expressed his enthusiasm about Blumenfeld's appointment, stating, "We are excited to welcome Mitch to the LabConnect team. His extensive experience in financial leadership is critical for driving profitable growth and operational excellence throughout our company."

As LabConnect’s CFO, Blumenfeld will oversee the organization’s global financial operations, including commercial finance, accounting, treasury, financial planning and analysis, tax, and investor relations. His primary focus will be to align the financial strategy with LabConnect's long-term objectives while enhancing the efficiency and effectiveness of its financial operations.

Expressing his anticipation for the new role, Blumenfeld commented, "I am excited to join LabConnect at such a pivotal time. The company is redefining central laboratory services globally, and I look forward to helping shape that journey."

About LabConnect

LabConnect is recognized as the world’s most agile central laboratory solutions partner. With more than 20 years of experience, the company offers customized, scalable, and orchestrated technological support services for clinical trials of all sizes and complexities. Having successfully managed over 2,000 clinical studies in 93 countries, LabConnect is the trusted partner for organizations within the biotechnology, pharmaceutical, and clinical research sectors.

With state-of-the-art operations and strategic alliances with leading global laboratories, LabConnect is well-positioned to provide access to the latest innovations and automation solutions. The firm delivers exceptional service through a comprehensive suite of centralized laboratory services, which include customized laboratory kits, advanced sample tracking, integrated logistics, standardized global sample processing, and a leading industry test catalog with over 20,000 validated assays.

LabConnect’s team of scientific experts supports preclinical and clinical studies through project management, bioanalytical management, specimen strategy, and logistical solutions. The company excels in data management, integrating complex datasets from various sources into a cohesive dataset ready for submission.